The US Food and Drug Administration (FDA) has pushed back the launch of its long-awaited product listing portal.
In an update, it promised to provide more information about the launch date for electronic and paper submission forms for cosmetic product facility registration and cosmetic product listing under the Modernization of Cosmetics Regulation Act of 2022 (MoCRA) in coming weeks.
Submission had been anticipated to go live last month.
In its update, the FDA reiterated its encouragement of electronic submissions to facilitate efficiency of data submission.
It added that the cosmetics industry can continue to prepare for registration and listing by reviewing FDA documents and being proactive in collecting the information required to complete their facility registrations and product listings.
The authority said it is currently in the process of obtaining approval by the Office of Management and Budget (OMB) in the Executive Office of the President, under the Paperwork Reduction Act for the proposed collection of registration and listing information, which is required before the portal goes live.
MoCRA is the first major update to the FDA’s authority over cosmetic products since 1938.
The new rules are effective from 29 December this year, and any brand distributing into the US must ensure that their practices comply with the new law.
Under MoCRA, all facilities (owned or operated before 29 December 2022) engaged in the manufacturing or processing of a cosmetic product for distribution in the US and the products themselves be registered with the FDA.
Those owning or operating a facility that first engaged after 29 December 2022, meanwhile, must register within 60 days of first engaging, or by 27 February 2024, whichever is later.
In March, the FDA suspended its Voluntary Cosmetic Registration Program, but has not yet replaced it with a new system under MoCRA.
